Efficacy and Safety of Topical Chloroquine in Mild to Moderate Dry Eye Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Topical Chloroquine in Mild to Moderate Dry Eye Disease

Published:2019-07-15 Issue:12 Volume:44 Page:1306-1312
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Titiyal Jeewan S.¹,Kaur Manpreet¹,Falera Ruchita¹,Bharghava Ashima¹,Sah Ramkishor¹,Sen Seema²

Affiliation:

1. Cornea, Cataract & Refractive Surgery Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institutes of Medical Sciences, New Delhi, India

2. Department of Ocular Pathology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institutes of Medical Sciences, New Delhi, India

Funder

FDC Limited

Publisher

Informa UK Limited

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2019.1641824

Reference30 articles.

1. TFOS DEWS II Definition and Classification Report

2. The Core Mechanism of Dry Eye Disease Is Inflammation

3. TFOS DEWS II Management and Therapy Report

4. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Dry Eye Disease Treatment: Evidence From Randomized Controlled Trials;Eye & Contact Lens: Science & Clinical Practice;2023-09-20

2. Impact of Topical Cyclosporine-A or Topical Chloroquine on Post-LASIK Ocular Surface Stability – A Randomized Controlled Trial;Current Eye Research;2023-03-02

3. Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems;Pharmaceuticals;2021-11-22

4. Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis;Travel Medicine and Infectious Disease;2021-11

5. Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial;Indian Journal of Medical Research;2021